Evidence mapPaperPMID 34544956Full record

ArticleInternal medicine (Tokyo, Japan)2022

Significance of Glycemic Variability in Diabetes Mellitus.

Yoshiki Kusunoki, Kosuke Konishi, Taku Tsunoda, Hidenori Koyama

Open access · diamondAbstract read
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 33 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Observational
  12. Article
  13. Olfactory function in diabetes mellitus.Journal of clinical & translational endocrinology · 2024
    Review
  14. Article
  15. Article
  16. To What Extent Is HbJournal of clinical medicine · 2024
    Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Yoshiki KusunokiDepartment of Diabetes, Endocrinology and Clinical Immunology, Hyogo College of Medicine, Japan.
Kosuke KonishiDepartment of Diabetes, Endocrinology and Clinical Immunology, Hyogo College of Medicine, Japan.
Taku TsunodaDepartment of Diabetes, Endocrinology and Clinical Immunology, Hyogo College of Medicine, Japan.
Hidenori KoyamaDepartment of Diabetes, Endocrinology and Clinical Immunology, Hyogo College of Medicine, Japan.
Hyogo Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The goal of diabetes treatment is to maintain good glycemic control, prevent the development and progression of diabetic complications, and ensure the same quality of life and life expectancy as healthy people. Hemoglobin A1c (HbA1c) is used as an index of glycemic control, but strict glycemic control using HbA1c as an index may lead to severe hypoglycemia and cardiovascular death. Glycemic variability (GV), such as excessive hyperglycemia and hypoglycemia, is associated with diabetic vascular complications and has been recognized as an important index of glycemic control. Here, we reviewed the definition and evaluated the clinical usefulness of GV, and its relationship with diabetic complications and therapeutic strategies to reduce GV.

Indexed as

Diabetes Mellitus, Type 2Diabetic AngiopathiesBlood GlucoseGlycated HemoglobinHumansQuality of LifeBlood GlucoseGlycated Hemoglobincontinuous glucose monitoringdiabetic macrovascular complicationsdiabetic microvascular complicationsglycemic variabilitytime in range

Identifiers

PMID34544956
PMCPMC8866772
OpenAlexW3200775034

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.